3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Leukemia, Myelomonocytic, Chronic
3
Myelodysplastic Syndromes
2
Leukemia
2
Sinonasal undifferentiated carcinoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Esthesioneuroblastoma, Olfactory
1
Clonal Cytopenia of Undetermined Significance
1
Chondrosarcoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Methotrexate
6
Cyclophosphamide
6
ponatinib
5
Cytarabine
5
merphos
4
Mycophenolic Acid
4
blinatumomab
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporine
3
venetoclax
2
fludarabine phosphate
2
bosutinib
2
Vincristine
2
Rituximab
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Idarubicin
2
Etoposide
2
Cladribine
2
CT-P10
2
Busulfan
2
prednylidene
1
pegfilgrastim
1
nilotinib
1
midostaurin
1
gilteritinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
enasidenib
×
1 year
×
Clear all
No trials found.